Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ranjeet Prasad Dash, Rana Rais & Nuggehally R. Srinivas. (2018) Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion. Xenobiotica 48:9, pages 945-957.
Read now
Read now
Raghava Choudary Palacharla, Ramakrishna Nirogi, Venkatesham Uthukam, Arunkumar Manoharan, Ranjith Kumar Ponnamaneni & Ilayaraja Kalaikadhiban. (2018) Quantitative in vitro phenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims. Xenobiotica 48:7, pages 663-675.
Read now
Read now
Sophia M. Shi & Li Di. (2017) The role of carbonyl reductase 1 in drug discovery and development. Expert Opinion on Drug Metabolism & Toxicology 13:8, pages 859-870.
Read now
Read now
Iva Boušová, Lenka Skálová, Pavel Souček & Petra Matoušková. (2015) The modulation of carbonyl reductase 1 by polyphenols. Drug Metabolism Reviews 47:4, pages 520-533.
Read now
Read now
Petra Malátková & Vladimír Wsól. (2014) Carbonyl reduction pathways in drug metabolism. Drug Metabolism Reviews 46:1, pages 96-123.
Read now
Read now
Articles from other publishers (14)
Nadia O Bamfo, Jessica BL Lu & Zeruesenay Desta. (2023) Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and Intestine. Drug Metabolism and Disposition 51:1, pages 54-66.
Crossref
Crossref
Mohamed‐Eslam F. Mohamed, Mukul Minocha, Sheryl Trueman, Tian Feng, Jeffrey Enejosa, Ogert Fisniku & Ahmed A. Othman. (2020) Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate. Clinical Pharmacology in Drug Development 10:3, pages 299-306.
Crossref
Crossref
Xin Yang, Wenyi Hua, Sangwoo Ryu, Phillip Yates, Cheng Chang, Hui Zhang & Li Di. (2018)
11
β
-Hydroxysteroid Dehydrogenase 1 Human Tissue Distribution, Selective Inhibitor, and Role in Doxorubicin Metabolism
. Drug Metabolism and Disposition 46:7, pages 1023-1029.
Crossref
Crossref
Jamie N. Connarn, Stephanie Flowers, Marisa Kelly, Ruijuan Luo, Kristen M. Ward, Gloria Harrington, Ila Moncion, Masoud Kamali, Melivin McInnis, Meihua R. Feng, Vicki Ellingrod, Andrew Babiskin, Xinyuan Zhang & Duxin Sun. (2017) Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers. The AAPS Journal 19:5, pages 1513-1522.
Crossref
Crossref
T.D. Nolin. 2017. Drug Metabolism in Diseases. Drug Metabolism in Diseases
91
113
.
Jamie N. Connarn, Ruijuan Luo, Jim Windak, Xinyuan Zhang, Andrew Babiskin, Marisa Kelly, Gloria Harrington, Vicki L. Ellingrod, Masoud Kamali, Melvin McInnis & Duxin Sun. (2016) Identification of non‐reported bupropion metabolites in human plasma. Biopharmaceutics & Drug Disposition 37:9, pages 550-560.
Crossref
Crossref
V. M. Fokina, M. Xu, E. Rytting, S. Z. Abdel-Rahman, H. West, C. Oncken, S. M. Clark, M. S. Ahmed, G. D. V. Hankins & T. N. Nanovskaya. (2016) Pharmacokinetics of Bupropion and Its Pharmacologically Active Metabolites in Pregnancy. Drug Metabolism and Disposition 44:11, pages 1832-1838.
Crossref
Crossref
Valentina M. Fokina, Holly West, Cheryl Oncken, Shannon M. Clark, Mahmoud S. Ahmed, Gary D.V. Hankins & Tatiana N. Nanovskaya. (2016) Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid. American Journal of Obstetrics and Gynecology 215:4, pages 497.e1-497.e7.
Crossref
Crossref
O. A. Fahmi, M. Shebley, J. Palamanda, M. W. Sinz, D. Ramsden, H. J. Einolf, L. Chen & H. Wang. (2016) Evaluation of CYP2B6 Induction and Prediction of Clinical Drug-Drug Interactions: Considerations from the IQ Consortium Induction Working Group--An Industry Perspective. Drug Metabolism and Disposition 44:10, pages 1720-1730.
Crossref
Crossref
B. T. Gufford, J. B. L. Lu, I. F. Metzger, D. R. Jones & Z. Desta. (2016) Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo. Drug Metabolism and Disposition 44:4, pages 544-553.
Crossref
Crossref
Jamie N. Connarn, Xinyuan Zhang, Andrew Babiskin & Duxin Sun. (2015) Metabolism of Bupropion by Carbonyl Reductases in Liver and Intestine. Drug Metabolism and Disposition 43:7, pages 1019-1027.
Crossref
Crossref
Osama Y. Alshogran, Judith Naud, Andrew J. Ocque, François A. Leblond, Vincent Pichette & Thomas D. Nolin. (2015) Effect of Experimental Kidney Disease on the Functional Expression of Hepatic Reductases. Drug Metabolism and Disposition 43:1, pages 100-106.
Crossref
Crossref
Lucie Skarydova, Radana Tomanova, Lucie Havlikova, Hana Stambergova, Petr Solich & Vladimir Wsol. (2014) Deeper Insight into the Reducing Biotransformation of Bupropion in the Human Liver. Drug Metabolism and Pharmacokinetics 29:2, pages 177-184.
Crossref
Crossref
Arne Meyer, Anna Vuorinen, Agnieszka E. Zielinska, Petra Strajhar, Gareth G. Lavery, Daniela Schuster & Alex Odermatt. (2013)
Formation of Threohydrobupropion from Bupropion Is Dependent on 11
β
-Hydroxysteroid Dehydrogenase 1
. Drug Metabolism and Disposition 41:9, pages 1671-1678.
Crossref
Crossref